It is expected that the COVID-19 epidemic will not end until the second half of 2021 after the vaccine is available
According to a survey of 221 executives and investors in the medical industry released by Lazard on Thursday, effective vaccine supply is the most concern of 71% of respondents.
61% of respondents believe that the most important factor in achieving the “new normal” after the outbreak is the availability of effective vaccines that are widely available.
Nearly three-quarters of people said that vaccines will not be widely available until the second half of 2021.
In a statement attached to the report, David Gluckman, global head of Lazard’s healthcare group, stated that medical industry leaders “have a clear understanding of how long it may take to develop a widely available effective vaccine to control the epidemic, and they expect this situation to be It will not be realized until a long time in 2021, if not later."